Page last updated: 2024-09-03

ly 293558 and Ischemia

ly 293558 has been researched along with Ischemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bowes, MP; Swanson, S; Zivin, JA	1

Other Studies

1 other study(ies) available for ly 293558 and Ischemia

Article	Year
The AMPA antagonist LY293558 improves functional neurological outcome following reversible spinal cord ischemia in rabbits. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 1996, Volume: 16, Issue:5 Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Blood Pressure; Ischemia; Ischemic Attack, Transient; Isoquinolines; Kinetics; Male; Paraplegia; Rabbits; Reperfusion Injury; Spinal Cord; Tetrazoles	1996

Article

Year

The AMPA antagonist LY293558 improves functional neurological outcome following reversible spinal cord ischemia in rabbits.

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 1996, Volume: 16, Issue:5

Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Blood Pressure; Ischemia; Ischemic Attack, Transient; Isoquinolines; Kinetics; Male; Paraplegia; Rabbits; Reperfusion Injury; Spinal Cord; Tetrazoles

1996